RecruitingPhase 3NCT07325292
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Sponsor: Sanofi
Cullman, AL · Homewood, AL · +32 more sites
3 recruiting multiple sclerosis studies with a site in Cullman, AL.
Sponsor: Sanofi
Cullman, AL · Homewood, AL · +32 more sites
Sponsor: TG Therapeutics, Inc.
Birmingham, AL · Cullman, AL · Huntsville, AL · +106 more sites
Sponsor: TG Therapeutics, Inc.
Birmingham, AL · Cullman, AL · +39 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.